FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sandoz Children's Cetirizine HCl Chewable Tablets 5 Recall

Children's Cetirizine HCl Chewable Tablets 5 mg, 30 count blister pack, Manufactured in…

Sandoz Incorporated · Broomfield, CO

Risk level
Class III
Reported by FDA
Oct 24, 2012
Recall ID
D-008-2013
Check your lot numberHow we source this data

Summary

Sandoz recalled Children's Cetirizine HCl Chewable Tablets 5 starting Sep 20, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-008-2013 on Oct 24, 2012. Reason: Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&2). Status: Terminated.

Why it was recalled

Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&2)

Product description

Children's Cetirizine HCl Chewable Tablets 5 mg, 30 count blister pack, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ NDC 0781-5283-64 --- ALSO sold under Major brand All Day Allergy Children's Cetirizine HCl 5 mg, 5 count blister pack, Major Pharmaceuticals, Livonia, MI NDC 0904-5878-33

Lot numbers, UPCs & expiration codes

NDC 0781-5283-64 lots: BT2862, BT7986, BT7994, BW0652, CC1961, and CA3437; NDC 0904-5878-33 lot BW0665.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-008-2013
Classification
Class III
Status
Terminated
Recall initiated
Sep 20, 2012
FDA report date
Oct 24, 2012
Quantity
67,937 x 30 tablet cartons; 24,640 x 5 tablet cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Incorporated

Original FDA data

Every field from FDA enforcement report D-008-2013, exactly as published.

Show all FDA fields
City
Broomfield
State
CO
Status
Terminated
Country
United States
Event ID
63224
Address
2555 W Midway Blvd
Code information
NDC 0781-5283-64 lots: BT2862, BT7986, BT7994, BW0652, CC1961, and CA3437; NDC 0904-5878-33 lot BW0665.
Postal code
80020-1632
Report date
Oct 24, 2012
Product type
Drugs
Recall number
D-008-2013
Classification
Class III
Recalling firm
Sandoz Incorporated
Product quantity
67,937 x 30 tablet cartons; 24,640 x 5 tablet cartons
Termination date
Jan 14, 2013
Reason for recall
Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&2)
Voluntary / mandated
Voluntary: Firm initiated
Product description
Children's Cetirizine HCl Chewable Tablets 5 mg, 30 count blister pack, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ NDC 0781-5283-64 --- ALSO sold under Major brand All Day Allergy Children's Cetirizine HCl 5 mg, 5 count blister pack, Major Pharmaceuticals, Livonia, MI NDC 0904-5878-33
Distribution pattern
Nationwide
Recall initiation date
Sep 20, 2012
Initial firm notification
Letter
Center classification date
Oct 18, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-008-2013, published Oct 24, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls